The National University of Singapore serves the island nation as a tertiary hospital, clinical training center, and research center for medical and dental faculties. With 1,160 beds serving more than 670,000 outpatients and 49,000 inpatients, NUS is ranked first in Singapore & Asia Pacific and 11th in the world, according to the 2019 QA World University Rankings. This prestigious research organization initiated a large randomized Phase III open-label prophylaxis trial among migrant workers at high-risk of COVID-19; this study is known as the DORM Trial. Among the prophylaxis under investigation, hydroxychloroquine and Ivermectin are included. The study is led by Senior Consultant, Division of Neurology, Department of Medicine at NUS, Associate professor Seet Chee Seong Raymond.
The COVID-19 Devastation
A crushing disease when in escalation, COVID-19 causes a lower respiratory tract infection dominated by symptoms of fever, cough, and sore throat. The incubation period was estimated at between 5 to 7 days, but could last as long as 14 days. Most COVID-19 cases are mild; respiratory involvement has been reported in about 5% of the population, requiring supplementary oxyg...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).